Best of April: Top 5 Insights In Clinical Trial Technology

#1 - eClinical Solutions Market To Double In 5 Years, As Sponsors Prioritize Efficiency

The global eClinical solutions market is projected to reach $22.1 million in 2029, double its presence in 2024. Experts discuss the specific solutions driving market growth and share how they impact clinical operations.

#2 - The Catch-22 Of eConsent: The Missed Opportunity For Improved Clinical Trials

eConsent technology is often praised for its potential to revolutionize clinical trials, yet it remains underutilized. This article explores the barriers holding eConsent back, using evidence from scientific literature, and proposes actionable solutions.

#3 - The Risks Of AI In Clinical Research From A Trial Management Perspective

Research professionals must use AI responsibly, especially when handling regulated, high-stakes clinical trial documentation. In part two of this series, explore the challenges of integrating AI into eTMF management and how to mitigate them.

#4 - A Data-Driven Approach To Clinical Trial Site Selection

Learn how by incorporating data-driven site selection and verification, sponsors can optimize resource allocation, enhance protocol compliance, and improve overall trial integrity.

#5 - Pros & Cons Of Using Wearables In Clinical Trials

What are the biggest advantages and challenges of using wearables in a clinical trial? And who do you need on your team to add wearables to a trial? These are the questions Bryan Hansen, Ph.D. of Johnson & Johnson Innovative Medicine answers in this Q&A.